AKYA: Akoya BioSciences, Inc. Common Stock Company Profile & Statistics

About

Akoya Biosciences Inc. offers comprehensive single-cell imaging solutions which allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. The company offer distinct solutions, the CODEX(R) and Phenoptics(TM) platforms, to serve the diverse needs of researchers across discovery, translational and clinical research. Akoya Biosciences Inc. is based in MARLBOROUGH, Mass.

Info & Links

CEO

Brian McKelligon

Headquarters

100 CAMPUS DRIVE, 6TH FLOOR
MARLBOROUGH, MA 01752, UNITED STATES

Auditor

RSM US LLP

Share holders

Employees

205

Akoya BioSciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

54.05M

Enterprise Value

119.76M

Enterprise Value/EBITDA(ttm)

-3.06

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

1.18

Price to Book(mrq)

7.48

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

58.30%

Operating Margin(ttm)

-57.44%

Profit Margin(ttm)

-69.79%

Return on Equity(ttm)

-162.99%

Return on Invested Capital(ttm)

-56.30%

Return on Assets(ttm)

-32.76%

Income Statement

Revenue(ttm)

81.67M

Revenue Per Share(ttm)

1.64

Gross Profit(ttm)

47.88M

EBITDA(ttm)³

-39.08M

Net Income Available to Common(ttm)

-55.37M

Diluted EPS(ttm)

-1.18

Share Statistics

Beta (5Y Monthly)

1.23

52-Week Change

-72.25%

S&P 500 52-Week Change

6.35%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

49.82M

Dividend Yield

0.00%

Float⁴

45.95M

% Held by Insiders

7.30%

% Held by Institutions

79.42%

Balance Sheet

Total Cash(mrq)

35.04M

Total Cash Per Share(mrq)

0.70

Total Debt(mrq)

77.48M

Total Debt/Equity(mrq)

1020.20%

Current Ratio(mrq)

2.61%

Quick Ratio(mrq)

1.85%

Book Value Per Share(mrq)

0.15

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.89

Free Cash Flow(ytd)

-46.56M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

AKYA

Akoya BioSciences, Inc. Common Stock

Akoya BioSciences, Inc. Common Stock Profile